STX-002 (Styx Biotechnologies)

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NameSTX-002 (Styx Biotechnologies)
Drug Alias NameSTX-002 (Styx Biotechnologies)STX-002STX002STX-ADC02
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker
Mechanisms of ActionAnti-Glypican-3DNA topoisomerase I inhibitors
TargetsGlypican-3DNA topoisomerase I
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStyx Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesStyx Biotechnologies Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A